	More harm than good? The UK National Screening Committee's latest review of prostate cancer screening. BJU Int Boshari T, Anderson A, Richards M. PMID: 42259762 [PubMed - as supplied by publisher]
	The atlas of abdominal organ remodeling in hepatocellular carcinoma patients: An artificial intelligence-based multicenter imaging study. Med Guo Y, Fu X, Li T, Wang N, Jiang S, Li S, Guo X, Wang R, Long S, Li M, Liu Q, Zhao K, Xie Y, Chen X, Wang L, Zheng C, Yang L. PMID: 42259298 [PubMed - as supplied by publisher]
	Association between postoperative Clostridioides difficile infection and outcomes following pancreatoduodenectomy for pancreatic cancer: a national cohort study. Surg Endosc Daniel F, Abdallah B, Chaitou AR, Makki M, Mrad R, Khalife M, Tamim H. PMID: 42257924 [PubMed - in process]
	Sequential alternation of nal-IRI/5-FU and gemcitabine/nab-paclitaxel versus nal-IRI/5-FU versus gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer: results of the randomized phase II PRODIGE 61-FUNGEMAX trial (France). EClinicalMedicine Taieb J, Pernot S, Thuillier F, Delattre A, Vo-Quang E, Petorin C, Bourgeois V, Tougeron D, Audemar F, Vitellius C, Mosser L, Desrame J, Di Fiore F, Rinaldi Y, Pellat A, Bolliet M, Watelle F, Perrier H, Dubreuil O, Lepage C, Bachet JB. PMID: 42256682 [PubMed]
	A clinician-centric intelligent method towards reliable pancreatic cancer vascular invasion assessment: a retrospective, multi-centre study. Lancet Reg Health West Pac Guo R, Zhang M, Zhu H, Tang X, Fu W, Li M, Hu H, Xiao X, Wang W, Liu YB, Feng ST, Chen T, Qian X. PMID: 42256486 [PubMed]
	Evaluation of cystic neoplasms using EUS, MRI, and CT scan and treatment strategy. Ann Med Surg (Lond) Larijani A, Gandomkar H, Jazi K, Anvari S, Souri Z. PMID: 42254187 [PubMed]
	Functional Interpretation of Recurrent Genetic Variants in Hepatocellular Carcinoma: Molecular Consequences and Clinical Relevance. Hum Mutat Ye Y, Xu Z, Wang J, Chen C, Peng Y, Li B. PMID: 42253501 [PubMed - in process]
	Evaluating the role of plan complexity metrics in online adaptive radiotherapy for pancreatic cancer patients. Med Phys Cavinato S, Galetto M, Scaggion A, Bettinelli A, Nardini M, Chiloiro G, Romano A, Paiusco M, Boldrini L, Placidi L. PMID: 42253183 [PubMed - in process]
	Periarterial Divestment in Locally Advanced Pancreatic Cancer: Systematic Review and Single-Arm Meta-Analysis. J Laparoendosc Adv Surg Tech A Tafner PFDA, Behs JP, Nava FM, Trindade MLU, Theis C, Poli de Figueiredo SM, Del Grande L, Marques FILCB, Bressan AK, Pompeu BF. PMID: 42253112 [PubMed - as supplied by publisher]
	Updates on Imaging Assessment of Pancreatic Cancer for Determining Anatomic and Biologic Resectability. Korean J Radiol Lee SS, Kim DW, Lee W, Kim KP. PMID: 42252995 [PubMed - as supplied by publisher]
	Efficacy of targeted hepatocellular carcinoma therapy using modified response evaluation criteria in solid tumors and alpha-fetoprotein: A single center retrospective exploratory study. Ann Hepatobiliary Pancreat Surg Lin K, Ye L, Jiang Z, Li R, Shi H, Yu Y. PMID: 42252118 [PubMed - as supplied by publisher]
	Cancer-associated and non-neoplastic fibrosis: Comparative mechanisms and emerging antifibrotic strategies. Biomed Pharmacother Riccò B, Grisendi G, Monaco AL, Giuggioli D, Clini E, Dominici M. PMID: 42251804 [PubMed - as supplied by publisher]
	Pancreas-contactless open gastrectomy for gastric cancer and postoperative pancreatic complications: A retrospective cohort study. Surg Oncol Fujita S, Harada H, Okuno K, Sakuraya M, Higuchi T, Kumagai K, Naitoh T, Kumamoto Y, Yamashita K, Hiki N. PMID: 42250430 [PubMed - as supplied by publisher]
	Comment on "Pancreas-contactless open gastrectomy for gastric cancer and postoperative pancreatic complications: A retrospective cohort study". Surg Oncol Sati DM, Shinde VD, Agarwal C. PMID: 42250429 [PubMed - as supplied by publisher]
	Impact of medical oncologist certification on survival outcomes in metastatic colorectal cancer: evidence from the SCRUM-Japan MONSTAR-SCREEN Observational Study. Int J Clin Oncol Seguchi K, Hashimoto T, Fujisawa T, Shibuki T, Morizane C, Nonomura N, Iwata H, Watari H, Okano S, Namikawa K, Naito Y, Bando H, Yoshino T. PMID: 42250141 [PubMed - as supplied by publisher]
	Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): A phase II study (NIRA-PANC). Oncologist Kasi A, Al-Rajabi RMT, Baranda JC, Saeed A, Dai J, Chalise P, Weir S, Sear B, Carroll E, Bradbury S, Tripathi A, Hyter S, Beeki V, McKittrick RJ, Kumer S, Schmitt T, Soper S, Godwin AK, Sun W. PMID: 42249558 [PubMed - as supplied by publisher]
	Head to head comparison of [(68)Ga]Ga-FAPI-04 and [(18)F]FDG PET/CT in the diagnosis and staging of pancreatic cancer: a prospective study. EJNMMI Res Yang R, Sun Y, An R, Chen X, Pang X, Zhang J, Wang J, Han J, Ma T, Wang M, Shi F, Guo B, Zhao X. PMID: 42249240 [PubMed - as supplied by publisher]
	Operation oncolysis: Reoviruses in the theater of cancer war. Adv Cancer Res Voon K, Siew ZY. PMID: 42248646 [PubMed - indexed for MEDLINE]
	Emerging role of interaction between m6A and main ncRNAs in pancreatic cancer. Cancer Treat Res Commun Rui X, Gao J, Bi Y, Han Z, Zhang X, Hao Y, Yang C, Peng Y, Dai X, Xia Y, Jin Y. PMID: 42248052 [PubMed - as supplied by publisher]
	Safety and feasibility of subtotal gastrectomy compared with completion total gastrectomy for remnant gastric cancer: A systematic review and meta-analysis. Surg Oncol Menegat BLRS, Menegat ALRS, Dantas CR, de Moraes FCA. PMID: 42248045 [PubMed - as supplied by publisher]

Articles 1 - 20 / 60324

Page 1 of 3017



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy